Related Experiment Videos
Interferon treatments: how to use an endogenous system as a therapeutic agent
1Institute of Virology, University of Rome, Italy.
Journal of Interferon Research
|May 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.
Medical microbiology and immunology·2008
What is the practical significance of antibodies to interferons?
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2006
Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients.
Cellular and molecular biology (Noisy-le-Grand, France)·2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005).
The Journal of antimicrobial chemotherapy·2006
Rapid activation of the interferon-gamma signal transduction pathway by inhibitors of tyrosine phosphatases.
Journal of interferon research·1994
Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.
Journal of interferon research·1994
Modulation of peripheral leukocyte counts and bone marrow function in mice by oral administration of interleukin-2.
Journal of interferon research·1994
IDO mutants cross resistant to type I interferon retain p91-dependent gene induction.
Journal of interferon research·1994
Interferon-alpha 2 produced by normal human leukocytes is predominantly interferon-alpha 2b.
Journal of interferon research·1994